Overcoming Challenges and Managing Costs in Industrializing Generative AI

About this session

Panel Discussion.

The adoption of Generative AI into clinical trials offers transformative potential, enhancing efficiency, accuracy, and innovation. However, scaling Generative AI involves addressing significant challenges and managing costs effectively. This session will delve into these issues, providing practical solutions and insights through expert discussions and practical case studies. Join us for this in-depth session to discover how to effectively industrialize Generative AI in clinical trials to drive innovation and efficiency in bringing new drugs to market.

Speakers

• 

  Nagaraja "Sri" Srivatsan

  CEO · Endpoint Clinical, Inc.

  Moderator

• 

  Prasanna Rao

  Chief Products and Innovation Officer · Saama

  Panelist

• KN

  Kannan Natarajan

  SVP · Pfizer Inc

  Panelist